6 results
8-K
EX-1.1
TPST
Tempest Therapeutics Inc
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
reasonable best estimate of the matters described therein.
(g) Statistical and Market-Related Data. The statistical, demographic and market-related data
PRE 14A
TPST
Tempest Therapeutics Inc
22 Apr 22
Preliminary proxy
4:01pm
-
Binary
Did Not
Disclose
Gender
Part I: Gender Identity
Directors
Part II: Demographic Background
African American or Black
Alaskan Native or Native … American
Asian
Hispanic or Latinx
Native Hawaiian or Pacific Islander
White
Two or More Races or Ethnicities
LGBTQ+
Did Not Disclose Demographic Background
8-K
EX-1.1
uhjy qyrs3gkqsu4eodf
23 Jul 21
Other Events
5:20pm
- Prev
- 1
- Next